Scarica l'app Stockscreener
8.07
0.12%
0.010
Dopo l'orario di chiusura:
8.08
0.010
+0.12%
Precedente Chiudi:
$8.06
Aprire:
$8.0712
Volume 24 ore:
53,093
Relative Volume:
0.04
Capitalizzazione di mercato:
$384.83M
Reddito:
-
Utile/perdita netta:
$-82.60M
Rapporto P/E:
-3.9175
EPS:
-2.06
Flusso di cassa netto:
$-48.61M
1 W Prestazione:
+0.00%
1M Prestazione:
+1.64%
6M Prestazione:
+243.40%
1 anno Prestazione:
+102.26%
Intervallo 1D:
$8.07
$8.08
Intervallo di 1 settimana:
$8.06
$8.10
Portata 52W:
$1.312
$8.10
Vigil Neuroscience Inc Stock (VIGL) Company Profile
Nome
Vigil Neuroscience Inc
Settore
Industria
Telefono
857-254-4445
Indirizzo
100 FORGE ROAD, WATERTOWN
Confronta VIGL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VIGL
Vigil Neuroscience Inc
|
8.07 | 376.17M | 0 | -82.60M | -48.61M | -2.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Vigil Neuroscience Inc Stock (VIGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Downgrade | Stifel | Buy → Hold |
| 2024-12-04 | Iniziato | William Blair | Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-10-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-03-31 | Iniziato | Mizuho | Buy |
| 2022-09-16 | Iniziato | Wedbush | Outperform |
| 2022-08-29 | Iniziato | H.C. Wainwright | Buy |
| 2022-02-01 | Iniziato | Guggenheim | Buy |
| 2022-02-01 | Iniziato | Jefferies | Buy |
| 2022-02-01 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-02-01 | Iniziato | Stifel | Buy |
Mostra tutto
Vigil Neuroscience Inc Borsa (VIGL) Ultime notizie
Vigil Neuroscience Inc. Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com
What analysts say about Vigil Neuroscience Inc. stockFree Investment Community - jammulinksnews.com
What drives Vigil Neuroscience Inc. stock priceGame-changing capital returns - jammulinksnews.com
Is Vigil Neuroscience Inc. a good long term investmentStrong return on assets - jammulinksnews.com
Vigil Neuroscience Awaits HSR Expiration for Sanofi Merger - The Globe and Mail
Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period By Investing.com - Investing.com Nigeria
Vigil Neuroscience merger with Sanofi clears U.S. antitrust waiting period - Investing.com Australia
How Vigil Neuroscience Inc. stock performs during market volatilityIntraday Trade Ideas - Newser
Why Vigil Neuroscience Inc. stock attracts strong analyst attention10x Potential Stocks - Newser
What makes Vigil Neuroscience Inc. stock price move sharplyFree VIP Investment Strategies - Newser
Brokerages Set Vigil Neuroscience, Inc. (NASDAQ:VIGL) PT at $10.80 - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, CHTR, VIGL on Behalf of Shareholders - MarketScreener
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc.VIGL - The Globe and Mail
TREM2 agonists reported in Vigil Neuroscience patents - BioWorld MedTech
Vigil Neuroscience (NASDAQ:VIGL) Stock Price Up 0.4% – Here’s What Happened - Defense World
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: TASK, VIGL, STRM, and CHTR - The Malaysian Reserve
Vigil Neuroscience Announces Special Meeting for Sanofi Merger Vote - TipRanks
Wall Street Analysts See a 26.1% Upside in Vigil Neuroscience (VIGL): Can the Stock Really Move This High? - Nasdaq
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView
Two Sigma Investments LP Acquires 41,836 Shares of Vigil Neuroscience, Inc. (NASDAQ:VIGL) - Defense World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders - MarketScreener
Wall Street Analysts Think Vigil Neuroscience (VIGL) Could Surge 26.9%: Read This Before Placing a Bet - MSN
Vigil Neuroscience Inc Azioni (VIGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):